EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 100 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,658 | -82.3% | 41,500 | -59.1% | 0.00% | -100.0% |
| Q2 2023 | $71,456 | -61.0% | 101,500 | -50.3% | 0.00% | -50.0% |
| Q1 2023 | $183,282 | +33.6% | 204,350 | +75.7% | 0.01% | +20.0% |
| Q4 2022 | $137,234 | -71.5% | 116,300 | +81.9% | 0.01% | -72.2% |
| Q3 2022 | $482,000 | +20.2% | 63,950 | +0.4% | 0.02% | +28.6% |
| Q2 2022 | $401,000 | -22.4% | 63,700 | +2.2% | 0.01% | -6.7% |
| Q1 2022 | $517,000 | +59.1% | 62,300 | -0.5% | 0.02% | +66.7% |
| Q4 2021 | $325,000 | -20.3% | 62,600 | +2.4% | 0.01% | -25.0% |
| Q3 2021 | $408,000 | +200.0% | 61,150 | +283.4% | 0.01% | +200.0% |
| Q2 2021 | $136,000 | +0.7% | 15,950 | +4.9% | 0.00% | 0.0% |
| Q1 2021 | $135,000 | -27.8% | 15,200 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $187,000 | – | 15,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $6,144,000 | 4.00% |
| P.A.W. CAPITAL CORP | 380,000 | $3,363,000 | 2.96% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $6,770,000 | 1.78% |
| Telemetry Investments, L.L.C. | 150,477 | $1,332,000 | 1.51% |
| 683 Capital Management, LLC | 2,683,600 | $23,750,000 | 1.26% |
| KNOTT DAVID M | 276,535 | $2,447,000 | 1.05% |
| Trellus Management Company, LLC | 226,000 | $2,000,000 | 1.04% |
| TOWERVIEW LLC | 140,000 | $1,239,000 | 0.77% |
| Vivo Capital, LLC | 1,791,257 | $15,853,000 | 0.56% |
| CAXTON CORP | 94,083 | $833,000 | 0.54% |